-
Sanofi's cracked quadrivalent influenza virus vaccine, VaxigripTetra®, was approved for sale in Chi...
Sanofi Valjia has made new progress in China.
2023-02-27 14:46 -
DS-8201 was approved in China to update the domestic progress of targeting HER-2 ADC
DS-8201/T-Dxd (Enhertu) was approved in China.
2023-02-27 14:40 -
Step on the gas pedal and activate the immune checkpoint molecule 4-1BB.
Double antibody research and development progress ahead.
2023-02-27 14:36 -
Conoya sells global interest in Claudin 11.88 ADC for $18.2 billion
CMG901 is an ADC product jointly developed by Kanoya and Lepu Biotechnology.
2023-02-23 14:34 -
Bioorg. Med. Chem. Lett. | PROTAC targets FLT-3 and c-KIT: a new approach to leukemia treatment
New breakthrough in leukemia treatment!
2023-02-23 14:32 -
The different paths of Chinese and foreign diabetes giants: double males and double bears
China's diabetes treatment market also has the soil for giant growth.
2023-02-23 14:31 -
The SINOVAC inactivated hepatitis A vaccine, Haliflex ®, was approved in Egypt
Sinovac vaccine goes to sea with good news.
2023-02-23 14:30 -
Nanobody preparation tips sharing
The unique physical and chemical stability of nanobodies provides new research tools for diagnosis and treatment.
2023-02-23 14:28 -
The first child to receive commercial Libmeldy gene therapy was no longer symptomatic
Libmeldy is the world's first lentiviral vector-based gene therapy.
2023-02-23 14:11 -
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobod...
Biocytogen launches new program.
2023-02-22 10:14
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- Covestro and Wanhua Reshape Gl... Aug 20, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
